Evaluation of Diffuse Myocardial Fibrosis in Hypertensive Left Ventricular Hypertrophy

Keywords

aimed among anti application assess assessed assessing assessment association beats benefits biomedical biopsy blood blue body bolus breath calculating cardiology causes characteristics cine circulation clinical clustered coefficient cohort compliance consisting contrast control controls coronary correlated degree described detect determination determined development diagnosis diastolic diffuse disease distribution dysfunction ejection engineering enhanced evaluation excluded expansion failure fibrosis focal fraction function gadolinium healthy heart heartbeats histological hold house hypertension hypertensive hypertrophy hypothesized implications important included indexed injection internal inversion inversions known late linearly locker look manually mapping maps mass matched measured mechanisms medicine minutes modified monitor mortality myocardial myocardium novel occur partition patients plot positive potential potentially preserved pressure previously processes program pulse quantify radiology readily recovery reduce reduced regress renal resolution respectively risk robust samples scanner scarring segmented significantly slope subjects subsequent suggesting suggests support surface systolic table tailed therapies therapy tightly underlie underlying unpaired valvular variability ventricular versus volume volunteers years